http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 22 Apr 2024 05:47:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html for the full story. http://www.streetinsider.com/Press+Releases/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html Mon, 22 Apr 2024 05:47:00 -0400 A.60012004 AMYT O.09377232 O.41505130 http://www.streetinsider.com/Press+Releases/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html for the full story. http://www.streetinsider.com/Press+Releases/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html Mon, 22 Apr 2024 05:47:00 -0400 A.60012004 AMYT O.09377232 O.41505130 http://www.streetinsider.com/Press+Releases/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html for the full story. http://www.streetinsider.com/Press+Releases/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html Mon, 22 Apr 2024 05:47:00 -0400 A.60012004 AMYT O.09377232 O.41505130 http://www.streetinsider.com/Press+Releases/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html for the full story. http://www.streetinsider.com/Press+Releases/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html Mon, 22 Apr 2024 05:47:00 -0400 A.60012004 AMYT O.09377232 O.41505130 http://www.streetinsider.com/PRNewswire/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html for the full story. http://www.streetinsider.com/PRNewswire/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html Mon, 22 Apr 2024 05:47:00 -0400 A.60012004 AMYT O.09377232 O.41505130 http://www.streetinsider.com/PRNewswire/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html for the full story. http://www.streetinsider.com/PRNewswire/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html Mon, 22 Apr 2024 05:47:00 -0400 A.60012004 AMYT O.09377232 O.41505130 http://www.streetinsider.com/PRNewswire/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html for the full story. http://www.streetinsider.com/PRNewswire/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html Mon, 22 Apr 2024 05:47:00 -0400 A.60012004 AMYT O.09377232 O.41505130 http://www.streetinsider.com/PRNewswire/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html for the full story. http://www.streetinsider.com/PRNewswire/Chiesi+Group%27s+2023+Revenue+Surpasses+%E2%82%AC3+Billion+Mark%2C+Reflecting+10%25+Growth+Year-on-Year+%28%2B12%25+%40CER%29%2C+Underlining+Commitment+to+Innovative%2C+Sustainable+Practices/23093117.html Mon, 22 Apr 2024 05:47:00 -0400 A.60012004 AMYT O.09377232 O.41505130 http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html for the full story. http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Mon, 05 Feb 2024 08:30:00 -0400 A.17150087 A.19655944 A.38474826 AMYT O.00532504 O.03307993 O.41505130 O.49223070 http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html for the full story. http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Mon, 05 Feb 2024 08:30:00 -0400 A.17150087 A.19655944 A.38474826 AMYT O.00532504 O.03307993 O.41505130 O.49223070 http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html for the full story. http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Mon, 05 Feb 2024 08:30:00 -0400 A.17150087 A.19655944 A.38474826 AMYT O.00532504 O.03307993 O.41505130 O.49223070 http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html for the full story. http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Mon, 05 Feb 2024 08:30:00 -0400 A.17150087 A.19655944 A.38474826 AMYT O.00532504 O.03307993 O.41505130 O.49223070 http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html for the full story. http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Mon, 05 Feb 2024 08:30:00 -0400 A.17150087 A.19655944 A.38474826 AMYT O.00532504 O.03307993 O.41505130 O.49223070 http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html for the full story. http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Mon, 05 Feb 2024 08:30:00 -0400 A.17150087 A.19655944 A.38474826 AMYT O.00532504 O.03307993 O.41505130 O.49223070 http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html for the full story. http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Mon, 05 Feb 2024 08:30:00 -0400 A.17150087 A.19655944 A.38474826 AMYT O.00532504 O.03307993 O.41505130 O.49223070 http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html for the full story. http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Mon, 05 Feb 2024 08:30:00 -0400 A.17150087 A.19655944 A.38474826 AMYT O.00532504 O.03307993 O.41505130 O.49223070 http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html for the full story. http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Mon, 05 Feb 2024 08:30:00 -0400 A.17150087 A.19655944 A.38474826 AMYT O.00532504 O.03307993 O.41505130 O.49223070 http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html for the full story. http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Mon, 05 Feb 2024 08:30:00 -0400 A.17150087 A.19655944 A.38474826 AMYT O.00532504 O.03307993 O.41505130 O.49223070 http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html for the full story. http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Mon, 05 Feb 2024 08:30:00 -0400 A.17150087 A.19655944 A.38474826 AMYT O.00532504 O.03307993 O.41505130 O.49223070 http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html for the full story. http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Mon, 05 Feb 2024 08:30:00 -0400 A.17150087 A.19655944 A.38474826 AMYT O.00532504 O.03307993 O.41505130 O.49223070 http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html for the full story. http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Mon, 05 Feb 2024 08:30:00 -0400 A.17150087 A.19655944 A.38474826 AMYT O.00532504 O.03307993 O.41505130 O.49223070 http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html for the full story. http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Mon, 05 Feb 2024 08:30:00 -0400 A.17150087 A.19655944 A.38474826 AMYT O.00532504 O.03307993 O.41505130 O.49223070 http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html for the full story. http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Mon, 05 Feb 2024 08:30:00 -0400 A.17150087 A.19655944 A.38474826 AMYT O.00532504 O.03307993 O.41505130 O.49223070 http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html for the full story. http://www.streetinsider.com/Globe+Newswire/Chiesi+Global+Rare+Diseases+Announces+Health+Canada+Approval+of+MYALEPTA%E2%84%A2+%28metreleptin+for+injection%29+for+the+Treatment+of+Patients+with+Lipodystrophy/22719185.html Mon, 05 Feb 2024 08:30:00 -0400 A.17150087 A.19655944 A.38474826 AMYT O.00532504 O.03307993 O.41505130 O.49223070 http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Receives+FDA+Approval+for+FILSUVEZ%C2%AE+%28birch+triterpenes%29+topical+gel+for+the+Treatment+of+Epidermolysis+Bullosa/22544610.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Receives+FDA+Approval+for+FILSUVEZ%C2%AE+%28birch+triterpenes%29+topical+gel+for+the+Treatment+of+Epidermolysis+Bullosa/22544610.html for the full story. http://www.streetinsider.com/Press+Releases/Chiesi+Global+Rare+Diseases+Receives+FDA+Approval+for+FILSUVEZ%C2%AE+%28birch+triterpenes%29+topical+gel+for+the+Treatment+of+Epidermolysis+Bullosa/22544610.html Tue, 19 Dec 2023 11:13:00 -0400 A.06822034 A.60012004 AMYT O.20026344 O.41505130